Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer

BACKGROUND: Inhibitors targeting VEGF and VEGFR are commonly used in the clinic, but only a subset of patients could benefit from these inhibitors and the efficacy was limited by multiple relapse mechanisms. In this work, we aimed to investigate the role of innate immune response in anti-angiogenic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xuyao, Wang, Yichen, Fan, Jiajun, Chen, Wei, Luan, Jingyun, Mei, Xiaobin, Wang, Shaofei, Li, Yubin, Ye, Li, Li, Song, Tian, Wenzhi, Yin, Kai, Ju, Dianwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907216/
https://www.ncbi.nlm.nih.gov/pubmed/31829270
http://dx.doi.org/10.1186/s40425-019-0812-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907216/
https://www.ncbi.nlm.nih.gov/pubmed/31829270
http://dx.doi.org/10.1186/s40425-019-0812-9

Ejemplares similares